Pharmigene, Inc. (TPEX:7595)

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Pharmacogenetic Diagnostic Products	108.91M
Pharmacogenetic Diagnostic Products Growth	184.00%
Labor	3.89M
Royalties	27.00K
Other	3.72M
Other Growth	-4.77%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Taiwan	103.56M
Taiwan Growth	-11.02%
Asia	8.95M
Asia Growth	-31.31%
Americas	3.44M
Americas Growth	24.97%
Europe	586.00K
Europe Growth	8.32%